2013-024 Resolution of the 12th Board of Directors of Jianfeng Group
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviations: Jianfeng Group Number: pro 2013-024
Zhejiang Jianfeng Group Co., Ltd. 12th Board of Directors Resolution Announcement
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
On August 2, 2013, Zhejiang Jianfeng Group Co., Ltd. issued the convening of the 8th Board of Directors by fax, e-mail, telephone , and personal delivery. The notice of the 12 th meeting, this meeting was held by a combination of on-site and communication. On August 14, 2013, the on-site meeting was held as scheduled in the conference room of Zhejiang Jinhua Jianfeng Building. Five people attended the on-site meeting. Four foreign directors Huang Sujian, Deng Mingran, Liu Jiajian and Zhang Yuyou voted by fax. The on-site meeting was presided over by Chairman Jiang Xiaomeng, and supervisors and senior managers of Company attended the meeting as nonvoting delegates, in accordance with the relevant regulations of the Company Law and the Articles of Association of the Company , the resolution made is legal and valid. After deliberation and voting, the following resolution was adopted:
1. 2013 semi-annual report After deliberation and voting, the board of directors adopted the 2013 semi-annual report of the company. Voting result: 9 votes in favor, 0 votes against and 0 abstentions. 2. Proposal on Jianfeng Pharmaceutical to Set up a Joint Venture to Cooperate in Developing New Drugs After deliberation and voting, the board of directors passed the proposal, agreeing that Jianfeng Pharmaceutical should contribute 2090
yuan in monetary installments and Shanghai Hansheng Biotechnology Co., Ltd. should contribute 1710 yuan in patented technology intellectual property rights to set up a joint venture, carry out research, development and operation of new anti-tumor drugs (YLK ). It is also agreed that Jianfeng Pharmaceutical will pay Shanghai Hansheng Biotechnology Co., Ltd. 400 yuan in cash compensation for early research and development in installments .
Voting result: 9 votes in favor, 0 votes against, 0 abstentions. After deliberation and voting on the 3.'s related party transaction proposal on the acquisition of the equity of peak cement, the board of directors passed the related party transaction proposal, agreeing that the company should acquire the 1.34 equity of Zhejiang peak cement co., ltd.
held by Jinhua peak union investment co., ltd. at a price of of 8.71 million yuan. Jiang Xiaomeng, Du Zihong and Yu Jianhong, directors of Guan of the company, avoided voting on the bill.
voting result: 6 votes in favor, 0 votes against, 0 votes abstained. For details, please refer to the Announcement of Related Transactions on the Acquisition of Equity Interest in Peak Cement (P.91 2013-025 ).
hereby announces
August 16, 2013
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
More information
The company's vocational skill level independently identifies two new occupations
A few days ago, after the examination and approval of the Jinhua Municipal Bureau of Human Resources and Social Security, and reported to the Provincial Department of Human Resources and Social Security for examination and filing, Jianfeng Group's independent identification level of vocational skills was based on last year. Two new occupations (types of work) are chemical inspectors and organic synthesis workers.
2022
05-20
On May 12, Cai Xiaochun, deputy secretary of the Party group of Zhejiang Federation of industry and commerce, and his party visited Jianfeng group for investigation, visited Jinxi factory area of Jianfeng pharmaceutical factory and Jinxi internationalization project site, and had a discussion with Jiang Xiaomeng, chairman of the group company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company.
2022
05-20
On the afternoon of April 6, Jiang Xiaomeng, chairman of the group company, was invited to participate in the Jinhua News Client Financial Media Interview column "Night Talk of the Two Sessions", as a representative of the Jinhua Municipal People's Congress, to talk about suggestions for the future development of Jinhua enterprises. As the chairman of the Jinhua City Federation of Industry and Commerce, Jiang Xiaomeng has a personal experience of various problems encountered in the development of Jinhua enterprises. After careful investigation and full preparation, he put forward two proposals on strengthening the empowerment and allocation of production factors and further enhancing the market competitiveness of enterprises in our city and further promoting the compliance construction of private enterprises in our city and reducing the risk of enterprise operation. In the "two sessions night talk" interview, he put forward his own views on these two topics.
2022
04-12
Group Companies Commend 2021 Advanced
On the morning of January 26, the group company held the 2021 annual summary commendation meeting to review the work of the previous year, make arrangements for the work of 2022, sign the 2022 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2021 advanced collectives and individuals.
2022
02-08
Group Company Convenes Workers' Representative and Trade Union Member Representative Conference
The group company held a representative meeting of staff representatives and trade union members, elected members of the eighth trade union committee and members of various special committees, and Shi Fu was elected chairman of the eighth trade union of the group trade union.
2022
02-08
The group company held an annual safety and environmental protection work conference to comprehensively summarize and review the safety and environmental protection work in 2021, make arrangements for the safety and environmental protection work in 2022, and sign the safety and environmental protection work responsibility system.
2022
02-08